Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Siobhan Fogarty to Chief Technical Officer
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
Via The Motley Fool
Exposures Product Safety
Tickers VRTX
Applied Therapeutics, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Applied Therapeutics, Inc. Investors Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds Applied Therapeutics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
MDC Associates Adapts to Evolving Trends in the 510(k) Submission Process
Via Press Release Distribution Service
Exposures Product Safety
The Original Pulled Oxtail Meat™ Changes the Game: Pioneering Convenience, Culinary Innovation, & Community Engagement
Via PRLog
Exposures Product Safety
Tickers PEP
Kaplan Fox Alerts Applied Therapeutics, Inc. (APLT) Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics, Inc. (APLT) Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces 1-for-100 Reverse Stock Split
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Via The Motley Fool
Exposures Product Safety
Tickers VRTX
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Via The Motley Fool
Exposures Product Safety
Tickers CRSP VRTX
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Tickers VRTX
Vertex Pharmaceuticals Stock Soars As Non-Opioid Pain Treatment Gets FDA Nod
Via Talk Markets
Topics Stocks / Equities
Exposures Product Safety
Tickers VRTX
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
United Health Products Provides Update on FDA PMA Application Process
Via NewMediaWire
Exposures Product Safety
Tickers UEEC
United Health Products Provides Update on FDA PMA Application Process
Via TheNewswire.com
Exposures Product Safety
Tickers UEEC
Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller
Via Investor's Business Daily
Exposures Product Safety
Tickers VRTX
Surf Up The Fun with a New Children’s Book that Celebrates the Magic of Building Sandcastles at the Jersey Shore
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Is Tonix Pharmaceuticals the Next Biotech Breakout?
Via MarketBeat
Exposures Product Safety
Tickers TNXP
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Revolutionary Sleep Again Pillow System Offers New Hope for Post-Surgery Recovery
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Latest Poll: More Than One-Third of Moderate Voters Do Not Trust Federal Health Agencies
Via Get News
Exposures COVID-19 Product Safety
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Ozempic Receives FDA Approval To Treat Kidney Disease
Via Benzinga
Exposures Product Safety
Tickers NVO
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.